Terms: = Kidney tumors AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791
3 results:
1. Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines.
Wang X; Hu J; Fang Y; Fu Y; Liu B; Zhang C; Feng S; Lu X
Cells; 2022 Jan; 11(3):. PubMed ID: 35159281
[TBL] [Abstract] [Full Text] [Related]
2. PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study.
Bosso D; Pagliuca M; Sonpavde G; Pond G; Lucarelli G; Rossetti S; Facchini G; Scagliarini S; Cartenì G; Daniele B; Morelli F; Ferro M; Puglia L; Izzo M; Montanaro V; Bellelli T; Vitrone F; De Placido S; Buonerba C; Di Lorenzo G
Medicine (Baltimore); 2017 Jun; 96(24):e6817. PubMed ID: 28614217
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin-1 increases expression of the lyt-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines.
Kurzrock R; Estrov Z; Ku S; Leonard M; Talpaz M
J Lab Clin Med; 1998 Mar; 131(3):261-8. PubMed ID: 9523851
[TBL] [Abstract] [Full Text] [Related]
